HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral Therapy
Open Access
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 15, 9-17
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 35 references indexed in Scilit:
- PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progressionNature, 2006
- Treatment interruptions in HIV-infected subjectsJournal of Antimicrobial Chemotherapy, 2006
- Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+T-Cell EpitopesJournal of Virology, 2006
- Expansion and Diversification of Virus-Specific T Cells following Immunization of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals with a Recombinant Modified Vaccinia Virus Ankara/HIV-1 Gag VaccineJournal of Virology, 2006
- Selective Escape from CD8 + T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 EvolutionJournal of Virology, 2005
- Enhanced Culture Assay for Detection and Quantitation of Latently Infected, Resting CD4+ T-Cells Carrying Replication-Competent Virus in HIV-1-Infected Individuals2005
- Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLANature, 2004
- Duration of antiviral immunity after smallpox vaccinationNature Medicine, 2003
- Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral LoadJournal of Virology, 2003
- Two Double‐Blinded, Randomized, Comparative Trials of 4 Human Immunodeficiency Virus Type 1 (HIV‐1) Envelope Vaccines in HIV‐1–Infected Individuals across a Spectrum of Disease Severity: AIDS Clinical Trials Groups 209 and 214The Journal of Infectious Diseases, 2000